Research & Development

Complementary to the contract research services, Bionos participates in various R&D projects in collaboration with national and international companies and public institutions.

H2020 – Phocnosis

The PHOCNOSIS project aims at the development and the preclinical validation of a nanotechnology-based handheld point-of-care testing (POCT) analysis device for its application in the early diagnosis of cardiovascular diseases (CVD). This POCT analysis device will significantly help in the implementation of mass screening programs, with the consequent impact on clinical management, reducing also costs of treatments, and increasing survival rates.

Reference: H2020-PHC-634013  –  https://cordis.europa.eu/project/rcn/193268_es.html

H2020 – AlgaeCeuticals (Marie Sklodowska-Curie actions)

Microalgae biomass represents a rich source for discovery. The potential for algae-based ingredients in the industry relies on the manipulation and targeting of ingredients to fit increasingly niche product specifications. Algae are exposed to extreme environment and thus have developed unique mechanism for protection. Furthermore, algae produce for the same reason different metabolites which we need to identify and exploit in a sustainable way for the production of food, drugs and cosmetics.

The AlgaeCeuticals project will take advantage of the native algae strains producing high added value products and through the application of novel omics technologies (genomics, transcriptomics, proteomics, enzymomics and metabolomics) as well as algae culture technologies and production of novel products. AlgaeCeuticals will screen and characterize algae biodiversity, develop and optimize algae culture systems, develop omics resources for algae and also develop downstream processing strategies and also develop novel products.

Reference: 778263  –  https://cordis.europa.eu/project/rcn/213018_es.html

University of Valencia – ICMOL

In collaboration with the Molecular Science Institute (ICMOL) from the University of Valencia, Bionos develops efficacy and functionality assays to validate the activity of new chemical entities, in order to market them as new products for the cosmetic and pharmaceutical industries.

The Institute of Molecular Science (ICMol), located at the Parc Cientific de la Universitat de València, was founded in 2000 and is recognized internationally as one of the pioneering centres for the research on molecular science. The ICMol employs more than 100 scientific researchers and houses the most advanced systems for the preparation, characterization and study of molecules and molecular materials. In the Centre, potential application of molecules and materials are explored, in different areas of current interest (molecular magnetism, molecular electronics, nanotechnology, biotechnology, catalysis, etc.).

IUCT-Inkemia

Bionos and IUCT-Inkemia through a Joint Venture project collaborate in the development of new functional ingredients for the cosmetic market. Bionos contributes its know-how and efficacy assays to validate the activity of new compounds, whereas Inkemia contributes with a library of bioactive compounds, obtained from remote places with special environmental conditions.

Inkemia’s mission is the generation, management and exploitation of knowledge of high technological value. The business base of Inkemia is the generation of knowledge, which is exploited through the promotion and sale of high value products and services for the chemical, food, pharmaceutical, biopharmaceutical and biotechnology fields.

Medical Research Institute Hospital La Fe (IIS La Fe)

Bionos collaborates in various projects with several research groups and services from Medical Research Institute Hospital La Fe. Through them, Bionos is in direct contact with doctors and researchers, allowing to meet the existing needs in the different medical fields and events that take place in a European pointer clinical and scientific environment.

The IIS La Fe is the area of biomedical research created between the University Hospital and Polytechnic La Fe, the University of Valencia, the Polytechnic University of Valencia, the Higher Council for Scientific Research (CSIC) and the Research Foundation of the La Fe Hospital from Valencian Community. The institute fosters and promotes excellence research, scientific and technological knowledge and its subsequent translation to the industry, as well as teaching and training. Re-accredited in 2014 by the Carlos III Health Institute, it is composed of 28 accredited research groups, 12 mixed units and other research groups.

IMAPEA/2016/43 project

PROJECT: IMAPEA / 2016/43 – “New drug based on SOD-enzymes for the treatment of neurodegenerative diseases”.

The main objective of this aid is the preparation of proposals for the participation of BIONOS in the call SME INSTRUMENT-Phase I. The project has had the help of IVACE within the program PREPARATION OF PROPOSALS FOR CALLS H2020 with a grant of 3,542.50 €, with funding from the European Regional Development Fund (ERDF), in a percentage of 50%, through the ERDF Operational Program of the Valencian Region 2014-2020.

ITAPIN/2017/570 project

PROJECT: ITAPIN/2017/570 – “Internationalization Strategic Plan.

The main objective of this aid is the preparation of the Internationalization Strategic Plan of the Bionos’ R&D services. The project has had the help of IVACE within the program HELP TO THE INTERNATIONALIZATION PLAN OF THE VALENCIA COMMUNITY PYMES (2017)  with a grant of 2.816,25 €, with funding from the European Regional Development Fund (ERDF), through the ERDF Operational Program of the Valencian Region 2014-2020.

EMP-FPSG/2016/5195 project

PROYECT: EMP-FPSG-2016-5195 – “Development and preclinical validation of a portable point-of-care (POC) analysis device”.

The main objective of this aid is the to foster de development of R&D activities and the creation of employment and quality, through hiring a graduate in professional training (FP) to carry out the development and preclinical validation of a portable point-of-care (POC) analysis device, based in various novel nanotechnological concepts for its application in the early diagnosis of cardiovascular diseases. This aid is financed by the State Agency for Research (Ministry of Economy, Industry and Competitiveness) and the State Program for the Promotion of Talent and its Employability, included in the State Plan for Scientific, Technical and Innovation Research 2013-2016.